Survival and proliferation factors of normal and malignant plasma cells. - Wikidata - awgldk - TriplyDB

Survival and proliferation factors of normal and malignant plasma cells.

Survival and proliferation factors of normal and malignant plasma cells.

http://www.wikidata.org/entity/Q35211028

about

The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature Suppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancer Science review: searching for gene candidates in acute lung injury.Heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor in normal and neoplastic hematopoiesis Treatment options and strategies for antibody mediated rejection after renal transplantation Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma Identification of midkine as a mediator for intercellular transfer of drug resistance Update on therapeutic options in Waldenström macroglobulinemia Zebrafish narrowminded disrupts the transcription factor prdm1 and is required for neural crest and sensory neuron specification Prdm1a is necessary for posterior pharyngeal arch development in zebrafish.MUC1 mucin interacts with calcium-modulating cyclophilin ligand.Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays.TPL2 kinase regulates the inflammatory milieu of the myeloma niche Quantitative trait loci mapping reveals candidate pathways regulating cell cycle duration in Plasmodium falciparum.Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis.Diffusion-weighted imaging for non-invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histology.A novel VHH antibody targeting the B cell-activating factor for B-cell lymphoma.Dyad of CD40/CD40 ligand fosters neuroinflammation at the blood-brain barrier and is regulated via JNK signaling: implications for HIV-1 encephalitis.Input of DNA microarrays to identify novel mechanisms in multiple myeloma biology and therapeutic applications.Gene expression of anti- and pro-apoptotic proteins in malignant and normal plasma cells.TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells An integrated genomic analysis of aryl hydrocarbon receptor-mediated inhibition of B-cell differentiation.Myelomagenesis: capturing early microenvironment changes Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1.Serum proinflammatory mediators at different periods of therapy in patients with multiple myeloma.Waldenstrom macroglobulinemia Interactions between tissue fibroblasts in lymph nodes and Hodgkin/Reed-Sternberg cells.Abnormal repression of SHP-1, SHP-2 and SOCS-1 transcription sustains the activation of the JAK/STAT3 pathway and the progression of the disease in multiple myeloma.A prospective study of circulating adipokine levels and risk of multiple myeloma.Microarray-based understanding of normal and malignant plasma cells.Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma.Hodgkin's lymphoma: molecular targets and novel treatment strategies.Recruitment and retention of B cells in the central nervous system in response to alphavirus encephalomyelitis.BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone Body mass index and physical activity at different ages and risk of multiple myeloma in the NIH-AARP diet and health study.Low Levels of Circulating Adiponectin Are Associated with Multiple Myeloma Risk in Overweight and Obese Individuals.Anthropometric characteristics and multiple myeloma risk.BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells Establishment of an immunoglobulin m antibody-forming cell response model for characterizing immunotoxicity in primary human B cells

P2860

Q24647037-1F799677-1FC5-4506-B226-D7091037BCAB Q24677026-3E10937C-6762-44F6-85C7-421E6CA60E2F Q24800666-14F2C16B-23D9-4F11-850A-0BF3875638AD Q26852845-51C23914-9872-4406-A7FC-FC23FC6D520E Q27021397-1BD62579-BCC8-4801-BBED-904300B25BA5 Q27027729-4AC25C27-5E22-458B-A374-9BCB7D39BE96 Q28251166-64504700-339F-447C-BAE7-A82D7E58670D Q28304195-9CD88A11-F9DE-4184-9856-FE012100FBA3 Q28659825-274A8FD1-D473-48E5-8F73-BB3CF96F7F0D Q30493475-95ADF878-A487-4BB5-8328-C88808FE2865 Q33398890-4A7262F3-1AB3-4DEE-8A66-9FF743960FBB Q33577408-88511CC9-9DD6-4443-9BC3-A4615677C324 Q33714724-7AE3B0E1-EAC7-44CF-80B5-6E5221144358 Q33721489-FD7FBE3E-303A-448E-9FEF-3DA7CA5DB637 Q33748979-31DDE4DD-EDE6-44A1-8FB2-DCAF8465F442 Q33881446-15A8E157-50BE-4A41-9208-1C6FD6DC03FC Q33907508-92981256-BF55-41F9-BD6A-894284FE0A32 Q34015684-93B0FF5C-1C02-40BA-B564-5BD7C7E6FDDA Q34022979-C4752C47-DB35-41F8-A021-6503C6BF33F1 Q34104277-1756BCB7-8173-4E33-9887-794E6A2F1AD9 Q34134557-1C406A03-4610-4993-9553-C040D5023DB0 Q34413378-E3FD7DC7-F491-41C4-8CFC-A79D016833E1 Q34519296-834A8042-9D7E-4B25-9E6A-6E9C9FE0CE45 Q34786411-F800044C-A9A7-4552-8FB6-F4ACE2F3AF18 Q34894332-351C4C69-73DD-4D17-9C90-8D485F818AC0 Q35097328-3DBEBEE7-4252-48AA-AA4D-0D1CDE90E1D3 Q35820996-6D44A45A-88C7-4F91-881F-B0FFA1B93CD7 Q36331908-A171BA2A-3627-4A42-B967-173AB1B1D735 Q36425446-941522BE-9250-489E-A811-2BD0F0E3459D Q36453354-A4EF7F08-4E5E-4517-8BFF-34B919CB276D Q36499443-C017E657-4492-43A3-8CA4-D1109A23535A Q36572545-D0ADFA38-99CF-455F-95BA-A77FE3C3307D Q36607157-81B72032-FD47-436A-A3BD-305AF48F5CF0 Q36663554-8CEE9801-D6C2-408A-912B-C7AA1ECAB64C Q36889493-9332261B-1B15-4E50-A0D4-56FB8A463AAC Q36930076-89B1FEFC-EA02-4160-912F-EA046073E2AD Q37176406-4019A9C4-1606-4CF6-907E-303928DF2BC7 Q37197900-9224E34D-FD70-4CB2-955B-8E8EFE85D231 Q37314430-ED85BBC7-5330-4770-B5E6-65223D9A7C41 Q37420414-C6576888-B2EF-4396-9F76-78259D409014

P2860

Survival and proliferation factors of normal and malignant plasma cells.

http://www.wikidata.org/entity/Q35211028

description

2003 nî lūn-bûn

@nan

2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Survival and proliferation factors of normal and malignant plasma cells.

@ast

Survival and proliferation factors of normal and malignant plasma cells.

@en

type

label

Survival and proliferation factors of normal and malignant plasma cells.

@ast

Survival and proliferation factors of normal and malignant plasma cells.

@en

prefLabel

Survival and proliferation factors of normal and malignant plasma cells.

@ast

Survival and proliferation factors of normal and malignant plasma cells.

@en

P1433

Q35211028-0A2DC1A7-F627-4EBA-9446-23CB73D29BE5

P1476

Q35211028-F2E4E2FC-74A1-4A99-9E2A-1DCF199E9D80

P2093

Q35211028-00EA79A8-3E61-43BF-B334-EA3F384103C2

Q35211028-0B65BD8E-6576-4D29-A7AB-A19576C98A75

Q35211028-36A21A19-BAFC-40C4-8EA6-639469A21BD2

Q35211028-756A9A87-DBB5-4CDF-BD96-EDB9A16B4FC1

Q35211028-907CD617-9135-4B16-BAD9-1C6D0C655073

Q35211028-BFFB42E6-A9B9-49AF-8EA5-135E1C3CB79E

Q35211028-D9523CFE-2B62-4594-8722-4F21A089071A

Q35211028-ED6EAE30-A063-4E37-BC87-DD1F3767795D

Q35211028-F23D050A-2AB1-4FD1-A602-100D52987650

P2860

Q35211028-07CDC2BE-45D4-4B72-A278-FF089C8823E2

Q35211028-0966E48E-ABE1-44DB-A383-E7ACF2E64E54

Q35211028-096AE786-81F8-452F-9B34-D97307F828E0

Q35211028-0ADA0896-CDA9-436C-9EEA-1153225CB4CD

Q35211028-13694F68-CA69-4AB6-B8D5-51C5D2B99638

Q35211028-1699FD8D-CDE7-48A1-BC9D-57B3A2A12114

Q35211028-1F90EBAC-C2F9-4915-8DAA-5EBD791400C6

Q35211028-22771851-8F50-4783-A67E-CA2807DAC85B

Q35211028-2A435E90-F8D4-4216-AAD9-1250848968AE

Q35211028-337F9158-8908-4216-A280-14D61F5675A4

P2888

Q35211028-1F96AF87-E751-484A-8BAD-560117DF9761

P304

Q35211028-05D8A5A5-BF73-48EF-8AB2-4DECF72ECD84

P31

Q35211028-17ABDD90-733F-4AEB-A863-EBD8C6F16EEF

P356

Q35211028-359682C7-779C-45E1-8B41-5F893C067338

P433

Q35211028-D606E922-114F-4B0F-884D-240F29830A53

P478

Q35211028-AC6D2643-5552-4D38-8133-33679BCE0625

P577

Q35211028-AB53C061-085F-4165-8288-508153718ED0

P5875

Q35211028-B0E83F5A-065E-44B9-833A-E0E0E1C48398

P698

Q35211028-7A190567-5BA2-4BEA-94C4-52505F3F1945

P932

Q35211028-9CE185DD-4605-4B0D-BF5C-DCB8598218DE

P356

P1433

International Journal of Hematology

P1476

Survival and proliferation factors of normal and malignant plasma cells.

@en

P2093

Bernard Klein

http://www.w3.org/2001/XMLSchema#string

Eric Jourdan

http://www.w3.org/2001/XMLSchema#string

Eric Legouffe

http://www.w3.org/2001/XMLSchema#string

Jean François Rossi

http://www.w3.org/2001/XMLSchema#string

Jerome Moreaux

http://www.w3.org/2001/XMLSchema#string

John De Vos

http://www.w3.org/2001/XMLSchema#string

Karene Mathouk

http://www.w3.org/2001/XMLSchema#string

Karin Tarte

http://www.w3.org/2001/XMLSchema#string

Michel Jourdan

http://www.w3.org/2001/XMLSchema#string

P2860

The major CD9 and CD81 molecular partner. Identification and characterization of the complexes

Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation

Plasma cell differentiation requires the transcription factor XBP-1

Regulatory mechanisms that determine the development and function of plasma cells

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor

Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1

Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma

High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies

TNF ligands and receptors in autoimmunity: an update.

P2888

P304

106-113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/BF02983377

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P577

2003-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5302374

http://www.w3.org/2001/XMLSchema#string

P698

12953803

http://www.w3.org/2001/XMLSchema#string

P932

2423421

http://www.w3.org/2001/XMLSchema#string